Fludrocortisone is effective in the management of tacrolimus-induced hyperkalemia in liver transplant recipients.

@article{Dick2011FludrocortisoneIE,
  title={Fludrocortisone is effective in the management of tacrolimus-induced hyperkalemia in liver transplant recipients.},
  author={Travis B. Dick and Alissa A. Raines and James B. Stinson and Dave Collingridge and Gordon E Harmston},
  journal={Transplantation proceedings},
  year={2011},
  volume={43 7},
  pages={
          2664-8
        }
}
Tacrolimus is the cornerstone of immunosuppression following liver transplantation (OLT). However, this agent may cause hyperkalemia by multiple mechanisms affecting potassium in the distal tubule. The purpose of this study was to evaluate the impact of fludrocortisone for the management of tacrolimus-induced hyperkalemia. Hospitalized adult OLT recipients who received fludrocortisone for tacrolimus-induced hyperkalemia were retrospectively identified. Change in serum potassium within 14 days… Expand
Cyclosporine nephrotoxicity and early posttransplant hyperkalemia in living-donor renal recipients: report of 4 cases.
TLDR
Successful treatment with fludrocortisone confirms that transitional pseudohypoaldosteronism has a potential nephrotoxic effect of cyclosporine, and should be considered a cause of hyperkalemia in renal transplant recipients. Expand
Incidence and Clinical Significance of Hyperkalemia Following Heart Transplantation.
TLDR
The incidence of HK following heart transplantation was high, with more than half of patients requiring any therapeutic interventions, and HK was related to an increase in infection events. Expand
High Blood Tacrolimus and Hyperkalemia in a Heart Transplant Patient
TLDR
A 43‐year‐old female patient (weight 54 kg) underwent orthotopic heart transplantation for dilated cardiomyopathy and postoperative recovery was uneventful and her left ventricle (LV) function was 60% on two‐dimensional echocardiography at the time of discharge. Expand
Heparin-Induced Hyperkalemia in a Patient Diagnosed with Thyroid Storm
TLDR
HIH can occur despite discontinuation of heparin, and TTKG can be helpful in guiding fludrocortisone treatment in this circumstance, and clinicians must be cautious of hyperkalemia. Expand
Treatment of hyperkalemia: something old, something new.
TLDR
Although bicarbonate is no longer recommended for acute management, it may be useful in patients with metabolic acidosis or intact kidney function and ZS-9 shows promise in the acute treatment of hyperkalemia and may make it possible to avoid or postpone the most effective therapy, emergency hemodialysis. Expand
Drug-Induced Hyperkalemia
TLDR
Increased awareness of drugs that can induce hyperkalemia, and monitoring and prevention are key elements for reducing the number of hospital admissions, morbidity, and mortality related to drug-induced hyperkAlemia. Expand
Incidental Hyperkalemia: An Unusual and Unexpected Case of Severe Hyperkalemia in an Otherwise Stable Post-Liver Transplant Recipient
TLDR
A 68-year-old man in stable condition was found to have a serum potassium level of 7.9 mmol/L one year after an orthotopic liver transplant, and his hyperkalemia resolved with conventional therapy and adjustment of his medications. Expand
The Many Faces of Calcineurin Inhibitor Toxicity-What the FK?
TLDR
The pharmacokinetics of CNI are briefly discussed, the numerous clinically relevant toxicities of commonly used CNIs, cyclosporine and tacrolimus are discussed, and multiple electrolyte derangements including hyperkalemia, hypomagnesemia, hypercalciuria, metabolic acidosis, and hyperuricemia are discussed. Expand
The Iraqi Journal of Veterinary Medicine, 40(1):161-166
1 Department of Physiology and Pharmacology, 2 Department of Anatomy, Histology and Embriology, College of Veterinary Medicine, Baghdad University, Iraq. E-mail: ali.alameedy89@yahoo.com Accepted:Expand
Clinical analysis of hyperkalemic renal tubular acidosis caused by calcineurin inhibitors in solid organ transplant recipients
  • W. Lin, L. Mou, +4 authors Y. Hu
  • Medicine
  • Journal of clinical pharmacy and therapeutics
  • 2017
Calcineurin inhibitor (CNI)‐based immunosuppressive regimen is widely used for preventing rejection in solid organ transplantation. Hyperkalemic renal tubular acidosis (RTA) caused by CNI is uncommonExpand
...
1
2
...

References

SHOWING 1-10 OF 18 REFERENCES
Hyponatraemia and hyperkalaemia are more frequent in renal transplant recipients treated with tacrolimus than with cyclosporin. Further evidence for differences between cyclosporin and tacrolimus nephrotoxicities.
  • R. Higgins, K. Ramaiyan, +4 authors H. Kashi
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2004
TLDR
Serum potassium levels were higher in tacrolimus-treated patients, and subjects with hyponatraemia were more likely to experience hyperkalaemia, consistent with qualitative differences between the nephrotoxicities of cyclosporin and tacro Limus. Expand
Influence of ciclosporin A on renal tubular function after kidney transplantation.
TLDR
CSA in therapeutic doses significantly impairs renal perfusion, glomerular filtration, distal acidification and the renin-aldosterone axis, and Hyporeninemic hypoaldosteronism could be demonstrated in 4 patients during the administration of CSA. Expand
Distal tubular acidosis induced by FK506.
TLDR
FK506 administration results in a decrease in the rate of hydrogen ion secretion by the collecting tubules, which is part of FK506 induced nephrotoxicity, the pathogenesis of this type of hyperkalemic metabolic acidosis found in patients treated with FK505 after renal transplantation has to be further elucidated. Expand
Control of hyperkalemia with fludrocortisone in a patient with systemic lupus erythematosus.
TLDR
It is concluded that fludrocortisone is a potent therapeutic approach for selected patients suffering from life threatening hyperkalemia, in whom potassium elevating drugs cannot be withdrawn. Expand
Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients.
TLDR
It is suggested that cyclosporine causes suppression of plasma renin activity and a tubular insensitivity to aldosterone, both of which may impair potassium excretion. Expand
Complete renal tubular acidosis late after kidney transplantation.
TLDR
It is concluded that a significant fraction of stable long-term renal transplant recipients with adequate graft function develop post-transplant RTA, with a preponderance for type Ia and type IV, and absence of type II. Expand
Intestinal Necrosis due to Sodium Polystyrene Sulfonate (Kayexalate) in Sorbitol
TLDR
It is highlighted that patients may be susceptible to SPS-induced necrosis even in the absence of ESRD, surgical intervention, or significant comorbidity. Expand
Ototoxicity of loop diuretics.
  • L. Rybak
  • Medicine
  • Otolaryngologic clinics of North America
  • 1993
TLDR
Animal experiments show that these drugs act on the stria vascularis, producing edema of these tissues and a temporary loss of function, resulting in a decrease of the endocochlear potential, which can result in secondary effects on sound-evoked measures of hearing. Expand
Damned if you do, damned if you don't: potassium binding resins in hyperkalemia.
TLDR
There is very little data to suggest that oral SPS given with 33% sorbitol (in the premixed form) or SPS powder in water orally or as an enema causes colonic necrosis, and when used appropriately, they appear to be clinically effective and reasonably safe. Expand
Distal renal tubular acidosis syndromes: a pathophysiological approach.
TLDR
The purpose of this review is to describe a revised classification based on the current understanding of collecting duct hydrogen ion secretion and ammonium addition to the lumen of the distal nephron of patients with distal acidification defects. Expand
...
1
2
...